Year: 2014
Type: article
Abstract: After the discovery of chlorpromazine in 1952 and the subsequent rise of biological psychiatry, the mainstream view of schizophrenia became that it was amenable only to drug treatment.But everything changed in 1997 when a pioneering trial found that drug resistant patients improved when given a form of cognitive therapy adapted to target delusions and hallucinations, two of the core "positive" symptoms of schizophrenia. 1 Many other trials-more than 50 to date-have since followed.
Source: BMJ
DOI: 10.1136/bmj.g2295
Authors: P. McKenna, D. Kingdon
Institutions: Fidmag Sisters Hospitallers, University of Southampton
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: Wellcome Trust
OpenAlex ID: W1975560743
